Acinetobacter baumannii -- United States
Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate (NMRC-BDRD), Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages - viruses that target and consume specific strains of bacteria - to treat a patient near death from a multidrug-resistant bacterium.
Infected with a
Read more about it at HealthMap Global Disease Alerts via http://bit.ly/2psMqYs
No comments:
Post a Comment